Insurers Battle Families Over Costly Drug for Fatal Disease

The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Muscular Dystrophy Aetna Inc Food and Drug Administration Sarepta Therapeutics Inc. Prices (Fares, Fees and Rates) Source Type: news